Press Releases

    • October 22, 2020

    Nemaura Medical to Present at Virtual Diabetes Technology Meeting 2020

    Loughborough, England – October 22, 2020 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology...

    Read more
    September 21, 2020

    Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products

    Clinically proven app from Healthimation LLC, to be paired with Company’s proBEAT™ non-invasive CGM system solution to offer convenient...

    Read more
    September 18, 2020

    Nemaura Medical Appoints Justin Mclarney as Chief Finance Officer

    Loughborough, England – September 18 , 2020 (BusinessWire) – Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical...

    Read more
    September 3, 2020

    Nemaura Medical to Provide US proBEAT™ launch update at The LD 500 Virtual Conference

    Loughborough, England, September 03, 2020 – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused...

    Read more
    August 19, 2020

    Nemaura Medical issues Presentation Pertaining to the use of Continuous Glucose Monitoring in COVID-19 Patients

    Loughborough, England, August 19, 2020 – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused...

    Read more
    August 17, 2020

    Nemaura Medical Reports Results and Provides Business Update for the First Quarter Ended June 30, 2020

    Loughborough, England, August 17, 2020 – Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a...

    Read more
    July 27, 2020

    Nemaura Enters into Letter of Intent to Acquire Healthimation, LLC to Augment proBEAT™ Launch in the U.S.

    Loughborough, England, July 27, 2020 — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    Read more
    July 23, 2020

    Nemaura Medical to Integrate Activity Data From Third Party Wearable Devices to Its proBEAT™ App

    Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagnostic...

    Read more
    July 14, 2020

    Nemaura Medical Evaluates New Applications for Continuous Lactate Monitoring using its BEAT™ platform

    Loughborough, England, July 14, 2020 – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    Read more
    July 7, 2020

    Nemaura Medical Submits PMA Application for sugarBEAT® to U.S. FDA

    Company to Participate in RedChip Webinar on Tuesday, July 7, at 11 a.m. ET to Discuss Commercialization Progress Loughborough,...

    Read more